ArticlePublic health challenges2024
Experience of people living with leprosy at leprosy settlements in Nigeria.
Article in Public health challenges, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bridging Financial Inclusion and Health Equity in LMICs: Evidence from a Half-Century of Bibliometric Data.International journal of environmental research and public health · 2026Article
- Experience of people living with leprosy at leprosy settlements in Nigeria.Public health challenges · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although Nigeria achieved the national leprosy elimination target of less than 1/10,000 population in 1998, factors such as culture, behavioural patterns and social determinants, among others, continue to contribute to an increase in leprosy cases and a poor state of living for individuals with leprosy in Nigeria. This study delves into the experiences of individuals residing in leprosy settlements in Nigeria. Methods: This study employed a community-based cross-sectional design, utilizing a concurrent mixed-methods approach for comprehensive data collection. Questionnaires, focus groups and interviews are conducted simultaneously. The research involves participants from seven leprosy communities across Nigeria's six geopolitical zones and Federal Capital Territory. Qualitative methods, including 14 focus group discussions and 6 key informant interviews, are complemented by quantitative questionnaires, engaging residents, leaders and nongovernmental organization (NGO) representatives. Respondents comprised 35 leprosy patients, 21 family members, 7 community leaders, 7 settlement officers and 2 organizational heads involved in leprosy control. Results: The results indicate significant access to healthcare (93.7%) and interest in self-care practices (95.2%), with a considerable proportion (74.6%) receiving free healthcare. Interview data underscore the limited government support, with NGOs and partners assuming a more substantial role. Qualitative insights from persons living with leprosy highlight financial struggles, stigmatization and substandard living conditions in settlements, exacerbated by limited government funding. This reliance on private and NGOs is further compounded by declining funding, hindering individuals' ability to start businesses and provide self-care. Conclusion: This study underscores the pressing need for increased government support, funding and better living conditions for individuals affected by leprosy in Nigeria. It highlights the significance of education, awareness campaigns and human rights promotion to combat stigma and enhance the quality of life for those living with leprosy. Moreover, the study advocates for the reintegration of affected individuals into their communities to foster societal inclusion and well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.